Dietary sodium restriction for mild hypertension in general practice
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Eighteen patients with stable mild hypertension (mean blood pressure 144/93 mm Hg) restricted their sodium intake for eight weeks while taking part in a double blind randomised crossover trial of slow sodium and placebo tablets. Mean 24 hour urinary sodium excretion was 143 mmol(mEq) during the period on slow sodium and 87 mmol during the period on placebo. Five patients were unable to reduce their sodium intake below 120 mmol, but the others had a mean 24 hour urinary sodium excretion of 59 mmol during the period on placebo.
There was no significant difference in blood pressure between the slow sodium and placebo treatment periods,
Introduction
Recent studies suggest that moderate dietary sodium restriction is effective in lowering blood pressure in hypertensive patients.' 2 These studies were based on patients referred to hospital and managed subsequently as inpatients or outpatients. We set out to establish whether dietary sodium restriction is also feasible and effective in the treatment of mild hypertension in general practice. the study owing to difficulty in complying with the diet: results are therefore presented for the remaining 18 patients and are based on all the data collected during each period of the trial unless stated otherwise. The statistical methods for design and analysis followed closely those given in two recent reviews of the crossover clinical trial. 4 Using published data6 on the within-person variability of blood pressure, we designed the study so that it had a 90%o power to detect a difference of 3 mm Hg in mean arterial pressure (diastolic plus one third pulse pressure) in a two sided test at the 50°level: consequently it had a power of 99°', to detect a difference of 5 mm Hg.
Estimates of the mean differences in blood pressure and other variables between the first and second four week periods, and between the periods on slow sodium and placebo tablets, were obtained after ensuring that there was no interaction between these effects (which would invalidate the remaining differences unless adequately explained). With equal numbers in each randomised group the two effects were estimated independently: their significance was evaluated by paired t tests.
Results

ORDER EFFECTS
Mean blood pressure fell significantly from 149 9/91 3 mm Hg during the run in period to 137 2/83-3 mm Hg during the first four weeks of the trial, and fell again slightly to 135 3/81-5 mm Hg during the second four weeks (table I) . There were no significant differences in blood pressure, body weight, or 24 hour urinary electrolyte excretion between the first and second four weeks of the trial. Figure 1 shows the mean sodium excretion for each patient in each period of the study, based on four single weekly 24 hour urine collections. Five patients did not manage to reduce their sodium intake below 120 mmol a day during the period on placebo, and three of these were also thought to have been non-compliant with the tablets, as their sodium intake was similar during the two periods (in two cases it was actually less during the period on slow sodium). The remaining 13 patients had a mean 24 hour urinary sodium excretion of 149 mmol during the run in period, 59 mmol during the period on placebo, and 139 mmol during the period on slow sodium (tables I, II). There were no significant differences in potassium intake throughout the study. Table II shows the mean blood pressure, body weight, 24 hour urinary electrolyte excretion, and plasma renin activity during the periods on slow sodium and placebo both for the whole group and for the 13 patients who achieved a satisfactory reduction in sodium intake. Only the differences in sodium excretion and plasma renin activity were statistically significant. Figure 2 shows the mean arterial pressure for each patient in each period of the trial, based on four weekly duplicate measurements.
No difference was found between blood pressure measured during the fourth week of placebo compared with the fourth week of slow sodium. These findings applied equally to patients receiving slow sodium during the first and second periods of the trial. BRITISH MEDICAL JOURNAL VOLUME 286 5 FEBRUARY 1983 in general practice. For example, Kawasaki et all8 and Van Brummelen et all 9 admitted their patients to hospital where they could administer low sodium diets of 9 and 50 mmol a day, respectively. These studies provide no guide to the effect and feasibility of achieving these levels of intake in free living subjects. Parijs et al20 studied patients with an initial mean diastolic pressure of 115 mm Hg, and though blood pressure fell by 7-7/4-4 mm Hg when sodium intake was reduced from 191 to 93 mmol daily, this finding may not apply to patients with mild hypertension.
Morgan et al12 reported a reduction in pressure in patients who reduced their sodium intake from 195 mmol to 157 mmol a day, but the evidence for this reduction in sodium intake was based on an unequal number of 24 hour urine collections from each patient, and one third of the patients provided no initial urine specimen.
MacGregor et al2 admitted patients to their study if diastolic pressure lay in the range 90-109 mm Hg after two months of observation. As mean diastolic pressure was 98 mm Hg, probably many of their patients had pressures high enough at the outset to justify drug treatment. Their data were also based on supine recordings. General practitioners do not as a rule measure blood pressure in this position, and it is not clear how these pressures relate to observations made in general practice. It cannot be assumed that supine pressures are comparable with sitting pressures, as standing pressures were on average 9 mm Hg higher than supine pressures throughout this study.
In view of this uncertainty we set out to study the feasibility The relatively low mean pressure of these patients may also be explained by two other factors. Firstly, the distribution of pressure in the range 90-104 mm Hg is weighted towards lower pressures. Secondly, the mean of six pressures must take into account the tendency of blood pressure to fall with repeated measurement. Based on only the three highest consecutive pressures of the six used to classify patients for this study, mean diastolic pressure was 96 9 mm Hg.
The study achieved its main aim of comparing blood pressure at two levels of sodium intake in patients with mild hypertension. Not all patients were willing or able to restrict their sodium intake, and some were also non-compliant with the tablets. Two patients (fig 1) actually had higher sodium excretion during the period on placebo and were thought not to have taken any of the tablets despite continuing to attend the weekly clinics. In general these results show that substantial reductions in sodium intake are feasible in general practice with willing patients given appropriate advice and support. Studies in which all subjects achieve low sodium intakes are probably not representative of the general population.
Compared with baseline measurements blood pressure fell in all patients during the study, irrespective of whether they were taking slow sodium or placebo tablets. The fall of 10 mm Hg in diastolic pressure is most likely explained by diminution of the alerting response and a small reduction in body weight.
There was no significant difference in mean arterial pressure between the periods on slow sodium and placebo tablets, despite a difference of 56 nmmol in 24 hour urinary sodium excretion and a twofold difference in plasma renin activity. In contrast, in a virtually identical study MacGregor et a!2 observed a fall of 7-1 mm Hg in mean arterial pressure between the fourth week of slow sodium and the fourth week of placebo, in association with a fall of 76 mmol in 24 hour urinary sodium excretion and a similar difference in plasma renin activity. Making this comparison in the 13 patients who reduced their sodium intake satisfactorily in our study, we found no significant difference in mean arterial pressure despite a fall of 57 mmol in sodium excretion: the 95l, confidence interval extended from a rise of 3-0 mm Hg to a fall of 5 4 mm Hg.
The difference in urinary sodium excretion during the periods on slow sodium in the two studies (162 v 142 mmol) was insufficient to account for the difference in blood pressure findings. There were more men and a greater racial mix in the study by MacGregor et al,2 and these differences may be important. The studies were not large enough to investigate differences between men and women and between blacks and whites.
Arguably our study did not last long enough to detect an effect of sodium restriction on patients with only mildly raised pressures. For example, Morgan et a121 found that blood pressure fell only marginally during the first six months of their study, and the maximum fall did not occur until 18 months. Nevertheless, the evidence that the fall in blood pressure in their study was accompanied by a reduction in sodium intake was unsatisfactory (see above). Most studies reporting an effect of sodium restriction on blood pressure have observed this effect within 28 days, and usually much sooner.
The major difference between these two studies which might explain their different results is the level of initial blood pressure in the two groups of patients. Together the results of the two studies are consistent with the suggestion that the effect of sodium restriction on blood pressure is related directly to the level of the initial blood pressure, in agreement with uncontrolled observations.23
Conclusion
Our study provides no evidence that moderate dietary sodium restriction lowers the blood pressure in patients with mild hypertension in the general population. Evidence from other studies is consistent with a hypotensive effect in patients with higher pressures, who would normally be treated with drugs. Sodium restriction may reduce drug requirements,24 but it is not clear whether the effect of a low sodium diet alone is large enough to provide adequate control of blood pressure in these patients. Even in the most convincing study of the effect of sodium restriction2 blood pressure stayed the same, or rose, during the period of low sodium diet in one third of the patients. Larger studies are required to determine the effect of sodium restriction on patients with different levels of blood pressure, and to identify factors which may indicate susceptibility to sodium restriction.
Introduction
It has long been thought that mechanical factors play a part in diabetic neuropathic ulcers of the sole. A recent study' showed clearly that these ulcers occur at the site of maximum pressure (vertical force), and although there are certainly other factors in their formation, the site of the ulcer is clearly determined by mechanical factors.
We have shown that both the vertical and shearing (longitudinal and transverse) components of force acting on the foot during walking are greatly modified by the type of footwear, and in particular that a below knee plaster cast with a rubber rocker greatly reduces all three components of force.2 This suggested that it might be possible to heal diabetic neuropathic ulcers in such a cast, and we therefore report the results of this method of treatment. We also give the results of measuring the components of force after the ulcers had been healed.
Method TREATMENT OF ULCERS
For treatment in a plaster cast the ulcer had to be moderately clean with healthy granulation tissue and without excessive discharge. We achieved this by bed rest, paring the overhanging edges of the ulcer, and on occasions antibiotics for a short period. Deep sepsis or osteomyelitis of the metatarsal head rendered the ulcer unsuitable for treatment by this method.
A conventional below knee plaster cast with a rubber rocker for weight bearing was then applied. On account of the sensory peripheral neuropathy great care was taken to apply adequate padding, and an extra layer of self adhesive foam rubber was applied around the malleoli. The forward projection of the cast was restricted to the level of the mid-shaft of the proximal phalanges of the toes, so that by dorsiflexion of the toes the dressing could be withdrawn, the ulcer inspected, and a new dressing inserted. Re-dressing was usually required daily, the dressing used being non-adhesive, presterilised Melolin (Smith and Nephew Ltd). The plaster was retained for two weeks after healing to allow some consolidation to occur.
In practice the plaster casts required changing after three or four weeks because of softening or soiling from discharge, or to allay anxiety about the state of the neuropathic foot in a plaster cast; however, no troublesome pressure problems were encountered.
ANALYSIS OF FORCES
Once the ulcer was healed it was possible to analyse the forces under the forefoot, as described.2 3 The three components of force (vertical, longitudinal shear, transverse shear) were analysed separately in different footwear using transducers attached to the sole of the foot with double sided adhesive tape. Transducers were located under the hallux, under the first, second and third, and fourth and fifth metatarsal heads, and under the midpoint of the heel.
Recordings were made with the patients walking barefoot, in a pair of conventional leather shoes, in the same shoes with a single 6 mm layer of low density Plastazote as an insole, in a pair of extra depth surgical shoes (Drushoe) designed to accommodate two 6 mm layers of Plastazote (one of medium density, one of low density), and in a below knee plaster cast.
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